Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine
- PMID: 3345930
- PMCID: PMC1433310
- DOI: 10.1136/gut.29.2.196
Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine
Abstract
Ileal permeability to different sized polyethyleneglycols (590-942 dalton PEG) was investigated peroperatively in 11 patients with Crohn's disease and seven with colonic carcinoma. A 15 cm ileal segment was converted into a tied loop, in which the PEG's were deposited. Absorption from the ileal segment was then measured as six-hour urinary recovery of the PEg dose. Polyethyleneglycol absorption in Crohn's disease was greater than in cancer patients and similar throughout the weight range, but in the cancer patients it was inversely proportional to molecular weight. Thus there was significantly greater absorption of the higher weights (greater than or equal to 678 dalton) in the Crohn's, than in the cancer patients. The apparently increased permeability of the small intestine in Crohn's disease may be an important factor in its pathogenesis.
Similar articles
-
Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.Acta Chir Scand. 1987;153(5-6):373-7. Acta Chir Scand. 1987. PMID: 3661039
-
Abnormal intestinal permeability pattern in colonic Crohn's disease. Absorption of low molecular weight polyethylene glycols after oral or colonic load.Scand J Gastroenterol. 1989 Jun;24(5):571-6. doi: 10.3109/00365528909093091. Scand J Gastroenterol. 1989. PMID: 2762756
-
Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.Acta Chir Scand. 1983;149(3):323-7. Acta Chir Scand. 1983. PMID: 6613469
-
Intestinal permeability in Crohn's disease.Acta Gastroenterol Belg. 1996 Jan-Mar;59(1):15-9. Acta Gastroenterol Belg. 1996. PMID: 8686412 Review.
-
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.J Leukoc Biol. 2005 Apr;77(4):460-5. doi: 10.1189/jlb.0904543. Epub 2004 Dec 23. J Leukoc Biol. 2005. PMID: 15618294 Review.
Cited by
-
Increased pulmonary and intestinal permeability in Crohn's disease.Gut. 1992 May;33(5):678-82. doi: 10.1136/gut.33.5.678. Gut. 1992. PMID: 1612487 Free PMC article.
-
Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.Gut. 1991 Jul;32(7):754-9. doi: 10.1136/gut.32.7.754. Gut. 1991. PMID: 1855681 Free PMC article.
-
Epithelial Barrier Function in Gut-Bone Signaling.Adv Exp Med Biol. 2017;1033:151-183. doi: 10.1007/978-3-319-66653-2_8. Adv Exp Med Biol. 2017. PMID: 29101655 Free PMC article. Review.
-
The immunopathogenesis of Crohn's disease: a three-stage model.Curr Opin Immunol. 2009 Oct;21(5):506-13. doi: 10.1016/j.coi.2009.06.003. Epub 2009 Aug 8. Curr Opin Immunol. 2009. PMID: 19665880 Free PMC article. Review.
-
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.Clin Exp Gastroenterol. 2017 Jul 17;10:147-168. doi: 10.2147/CEG.S136803. eCollection 2017. Clin Exp Gastroenterol. 2017. PMID: 28761367 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical